Skip to main content
SpringerLink
Log in

Treating critically ill anaemic patients with erythropoietin: why not?

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vlaar AP, Oczkowski S, de Bruin S, Wijnberge M, Antonelli M, Aubron C, Aries P, Duranteau J, Juffermans NP, Meier J, Murphy GJ, Abbasciano R, Muller M, Shah A, Perner A, Rygaard S, Walsh TS, Guyatt G, Dionne JC, Cecconi M (2020) Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med 46:673–696

    Article  Google Scholar 

  2. Lasocki S, Pène F, Ait-Oufella H, Aubron C, Ausset S, Buffet P, Huet O, Launey Y, Legrand M, Lescot T, Mekontso Dessap A, Piagnerelli M, Quintard H, Velly L, Kimmoun A, Chanques G (2020) Management and prevention of anaemia (acute bleeding excluded) in adult critical care patients. Ann Intensive Care. https://doi.org/10.1186/s13613-020-00711-6

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lasocki S, Pène F, Ait-Oufella H, Aubron C, Ausset S, Buffet P, Huet O, Launey Y, Legrand M, Lescot T, Mekontso Dessap A, Piagnerelli M, Quintard H, Velly L, Kimmoun A, Chanques G (2020) Management and prevention of anaemia (acute bleeding excluded) in adult critical care patients. Anaesth Crit Care Pain Med. https://doi.org/10.1016/j.accpm.2020.04.004

    Article  PubMed  PubMed Central  Google Scholar 

  4. Litton E, Latham P, Inman J, Luo J, Allan P (2019) Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intensive Care Med 45:1190–1199

    Article  Google Scholar 

  5. Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H (2017) Harms of off-label erythropoiesis-stimulating agents for critically ill people. Cochrane Database Syst Rev (Online) 8:CD010969

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département Anesthésie Réanimation, Université d’Angers, CHU Angers, 4 rue Larrey, 49933, Angers Cedex 9, France

    Sigismond Lasocki

  2. Service de Médecine Intensive et Réanimation, Université de Lorraine, CHRU de Nancy, Inserm U1116, Brabois, Nancy, France

    Antoine Kimmoun

  3. Département Anesthésie Réanimation, Hopital Saint-Éloi Hospital, Et PhyMedExp, INSERM, CNRS, Université de Montpellier, Montpellier, France

    Gerald Chanques

  4. Service d’Anesthésie Réanimation, APHM, CHU Timone, Marseille, France

    Lionel Velly

  5. MeCA, Institut de Neurosciences de La Timone, UMR 7289, Aix Marseille Université, Marseille, France

    Lionel Velly

  6. Service de Médecine Intensive et Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris Centre, Université de Paris, Paris, France

    Frédéric Pène

Authors
  1. Sigismond Lasocki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antoine Kimmoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerald Chanques
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lionel Velly
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frédéric Pène
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sigismond Lasocki.

Ethics declarations

Conflicts of interest

SL: lecturer personally funded by Pfizer, Vifor Pharma, Masimo; consulting for Pfizer, Vifor Pharma; research support from Vifor Pharma; AK: lecturer personally funded by Aspen Medical France, Gilead, Baxter, MSD, Aguetant. GC: lecturer personally funded by Aspen Medical France, Orion Pharma; consulting for Orion Pharma. FP: consulting for Alexion Pharma (institutionally funded). LV declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lasocki, S., Kimmoun, A., Chanques, G. et al. Treating critically ill anaemic patients with erythropoietin: why not?. Intensive Care Med 46, 1794–1795 (2020). https://doi.org/10.1007/s00134-020-06175-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-020-06175-3

Search

Navigation